Amarin | AMRN - Despesa De Juros Sobre A Dívida

Preço das Ações
14.49
Mudança Diária
-0.51 -3.40%
Mensal
-7.29%
Anual
58.50%
Q1 Previsão
14.05




Despesa De Juros Sobre A Dívida Alterar Data
AbbVie USD 740M 40M 2025-06
Alnylam Pharmaceuticals USD 129.34M 84.94M 2025-12
Amarin USD 3K 5K 2024-12
AstraZeneca USD 484M 181M 2025-12
BioCryst Pharmaceuticals USD 14.14M 5.53M 2025-12
DBV Technologies USD 461K 323.71K 2025-03
Esperion Therapeutics USD 22.64M 585K 2025-12
GlaxoSmithKline GBP 188M 21M 2025-12
Halozyme Therapeutics USD 4.91M 615K 2025-12
Heron Therapeutics USD 600K 100K 2024-12
Ionis Pharmaceuticals USD 18M 0 2025-12
Nektar Therapeutics USD 6.02M 420K 2024-09
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 304M 23M 2025-12